Literature DB >> 29700607

Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia.

Petra Majerova1, Ralph M Garruto2, Andrej Kovac3.   

Abstract

Parkinsonism-dementia complex of Guam (Guam PDC) is a neurodegenerative disease with parkinsonism and early onset Alzheimer-like dementia. Guam PDC belongs to the family of neurodegenerative disorders, known as tauopathies, which are histopathologically characterized by abnormal deposition of microtubule-associated protein tau. While changes in the blood-brain barrier (BBB) in Alzheimer's disease are increasingly recognized, dysfunction of BBB in Guam PDC has not been extensively studied. In this study, we characterized cerebrovascular changes in the patients with Guam PDC. The brain tissue from ten post-mortem Guam PDC patients and six non-demented controls were assessed for structural and functional changes in BBB. Entorhinal cortex sections were immunostained for the markers of brain endothelial cells (claudin-5, occludin, and collagen IV) and inflammation (VCAM-1, ICAM-1, P-Selectin, and E-Selectin). The ultrastructure of brain capillaries was investigated by confocal microscopy and morphological changes and intensity alterations were evaluated. We found a significant decrease of tight junction proteins and the upregulation of adhesion molecules that correlated with the presence of neurofibrillary tangles. In addition, we showed the presence of CD3+-positive cells in the brain areas affected by pathological lesions. Our findings indicate that pathological lesions in Guam PDC are associated with inflammatory changes of brain capillaries and could mediate transmigration of cells to the brain parenchyma.

Entities:  

Keywords:  Blood–brain barrier; Neurofibrillary tangles; Parkinsonism–dementia complex of Guam; Tau protein

Mesh:

Substances:

Year:  2018        PMID: 29700607     DOI: 10.1007/s00702-018-1883-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  36 in total

1.  Alzheimer's neurofibrillary changes. A topographic study.

Authors:  A HIRANO; H M ZIMMERMAN
Journal:  Arch Neurol       Date:  1962-09

2.  Misfolded truncated protein τ induces innate immune response via MAPK pathway.

Authors:  Andrej Kovac; Norbert Zilka; Zuzana Kazmerova; Martin Cente; Monika Zilkova; Michal Novak
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

3.  Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease.

Authors:  R Mena; P C Edwards; C R Harrington; E B Mukaetova-Ladinska; C M Wischik
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

4.  Regional distribution of cortical microglia parallels that of neurofibrillary tangles in Alzheimer's disease.

Authors:  L G Sheffield; J G Marquis; N E Berman
Journal:  Neurosci Lett       Date:  2000-05-19       Impact factor: 3.046

5.  Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.

Authors:  Isidre Ferrer; Irene López-González; Margarita Carmona; Laura Arregui; Esther Dalfó; Benjamin Torrejón-Escribano; Roberta Diehl; Gabor G Kovacs
Journal:  J Neuropathol Exp Neurol       Date:  2014-01       Impact factor: 3.685

6.  Distinct pathological features of the gallyas- and tau-positive glia in the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.

Authors:  K Oyanagi; T Makifuchi; T Ohtoh; K M Chen; D C Gajdusek; T N Chase
Journal:  J Neuropathol Exp Neurol       Date:  1997-03       Impact factor: 3.685

7.  Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease.

Authors:  E Farkas; G I De Jong; R A de Vos; E N Jansen Steur; P G Luiten
Journal:  Acta Neuropathol       Date:  2000-10       Impact factor: 17.088

Review 8.  The role of TIMPs in regulation of extracellular matrix proteolysis.

Authors:  Valerie Arpino; Michael Brock; Sean E Gill
Journal:  Matrix Biol       Date:  2015-03-21       Impact factor: 11.583

9.  Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.

Authors:  Walter G Bradley; Deborah C Mash
Journal:  Amyotroph Lateral Scler       Date:  2009

10.  DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope.

Authors:  Lubica Vechterova; Eva Kontsekova; Norbert Zilka; Miroslav Ferencik; Rivka Ravid; Michal Novak
Journal:  Neuroreport       Date:  2003-01-20       Impact factor: 1.837

View more
  5 in total

1.  Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies.

Authors:  Petra Majerova; Alena Michalicova; Martin Cente; Jozef Hanes; Jozef Vegh; Agnes Kittel; Nina Kosikova; Viera Cigankova; Sandra Mihaljevic; Santosh Jadhav; Andrej Kovac
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

Review 2.  Intersection of pathological tau and microglia at the synapse.

Authors:  Thomas Vogels; Adriana-Natalia Murgoci; Tomáš Hromádka
Journal:  Acta Neuropathol Commun       Date:  2019-07-05       Impact factor: 7.801

Review 3.  Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances.

Authors:  Xiaoqian Niu; Jiejian Chen; Jianqing Gao
Journal:  Asian J Pharm Sci       Date:  2018-10-22       Impact factor: 6.598

Review 4.  Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.

Authors:  Elisa Canepa; Silvia Fossati
Journal:  Front Neurol       Date:  2021-01-07       Impact factor: 4.003

5.  Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease.

Authors:  Annie G Bryant; Miwei Hu; Becky C Carlyle; Steven E Arnold; Matthew P Frosch; Sudeshna Das; Bradley T Hyman; Rachel E Bennett
Journal:  Front Neurol       Date:  2020-09-16       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.